Level of markers of neurodegeneration in patients with ocular ischemic syndrome

Title:

Level of markers of neurodegeneration in patients with ocular ischemic syndrome
Level of markers of neurodegeneration in patients with ocular ischemic syndrome

Creator:

Kamilov, Halidjan, Kasimova, Munirahon, and Makhkamova, Dilbar

Contributor:

Kamilov, Halidjan, Kasimova, Munirahon, and Makhkamova, Dilbar

Identifier:

https://cdk.lib.cas.cz/client/handle/uuid:bmc15010759-e7b8c271-ffbf-442b-9313-113bab5228e9
uuid:bmc15010759-e7b8c271-ffbf-442b-9313-113bab5228e9
local:bmc15010759
http://ojs.journals.cz/index.php/EMHPJ/issue/archive
isrc: xxx
local: bmc15010759

Subject:

oční nemoci--patologie, biologické markery--analýza--krev, proteiny S100--analýza--krev, fosfoenolpyruváthydratáza--analýza--krev, slzy--chemie, ischemie--diagnóza--patofyziologie, atrofie optického nervu--diagnóza--patofyziologie, staří, ženské pohlaví, lidé, mužské pohlaví, lidé středního věku, and oční ischemický syndrom

Type:

model:article, article, Text, srovnávací studie, and TEXT

Format:

electronic, electronic resource, remote, and elektronický zdroj

Description:

The purpose of this study was to investigate the content neurospecific markers protein S-100 and neuroenolaza in blood serum and tear fluid of patients with ocular ischemic syndrome. Material and methods. We observed 43 patients aged 57 to 79 years, mean age 67.3 ± 2.7 years. Control group consisted of 11 volunteers without ophthalmic symptoms. The main group consisted of 32 patients with OIS. The neurospecific proteins S100 and NSE were investigated in blood serum and tear fluid. Results. The study found that in patients of the control group the content of protein were within the normal range: S -100 in the tear fluid – 0,0662 ± 0,00335 mkg/l, in the blood serum 0,0508 ± 0,00241 mkg/l. In patients of the main group the indicators of protein in the tear fluid were elevated in all patients - 3,12 ± 0,246 mkg/l ( p<0.005). The normal evels in blood serum of marker S-100 was in 30 patients - 0,0589 ± 0,00303 mkg/l, while, in 2 patients protein S-100 were raised and averaged 0,2175±0,00725 mkg/l. It was found that in patients of the control group content of protein NSE in the tear fluid and blood serum were within normal values - 15,86 ± 0,148 Ng/ml, 15,60 ± 0,202 Ng/ml respectively. In the main group the amount of protein NSE tended to increase in the tear fluid in 23 patients and averaged 33,012 ± 3,2626 Ng/ml (p<0.005), a significant decrease the quantity of protein was observed in 9 patients, which amounted to 5,166 ± 0,8301 Ng/ml. At normal levels in the blood serum protein NSE detected in 30 patients and averaged 14,48 ± 0,263 Ng/ml, whereas, in 2 patients there was a significant increase of content of protein NSE and was 27,47 ± 3,068 Ng/ml. Conclusions. Thus, changes in the concentration of S100 and neuroenolaza in the tear fluid in patients with ocular ischemic European Medical, Health and Pharmaceutical Journal ISSN 1804-5804 syndrome allow to identify as marker of nerve cells damage of the eye, contributing to the definition in conjunction with other signs of stage and etiology of the disease., Halidjan Kamilov, Munirahon Kasimova, Dilbar Makhkamova, and Literatura

Language:

English

Rights:

http://creativecommons.org/publicdomain/mark/1.0/
policy:public

Relation:

European medical, health and pharmaceutical journal--MED00177703

Source:

European medical, health and pharmaceutical journal : open access reviewed journal | 2014 Volume:7 | Number:2

Harvested from:

CDK

Metadata only:

false

Date:

2014